IPSEF
Price:
$113.13
Market Cap:
$13.20B
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cabometyx, a tyrosine kinase inhibitor to treat second line pancreatic and extra-pancreatic neuroendocrine tumors; Onivyde, an irinotecan liposome injection for the treatment of pancreatic cancer; Decapeptyl for the treatment of advanced metastatic prostate cancer; Tazverik, a chemotherapy-free EZH2a inhibitor that is in phase III clinical trial for the treatment of second line follicular lymphoma; Tovorafenib that is in phase III clinical trial to ...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2009-09-21
Stock Exchange
OTC
Ticker
IPSEF
According to Ipsen S.A.’s latest financial reports and current stock price. The company's current ROE is 11.33%. This represents a change of 108.85% compared to the average of 5.43% of the last 4 quarters.
The mean historical ROE of Ipsen S.A. over the last ten years is 15.67%. The current 11.33% ROE has changed -27.66% with respect to the historical average. Over the past ten years (40 quarters), IPSEF's ROE was at its highest in in the December 2006 quarter at 39.78%. The ROE was at its lowest in in the December 2019 quarter at -15.47%.
Average
15.67%
Median
17.35%
Minimum
-3.14%
Maximum
25.71%
Discovering the peaks and valleys of Ipsen S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 23.93%
Maximum Annual ROE = 25.71%
Minimum Annual Increase = -920.11%
Minimum Annual ROE = -3.14%
| Year | ROE | Change |
|---|---|---|
| 2025 | 10.25% | 23.93% |
| 2024 | 8.27% | -50.90% |
| 2023 | 16.85% | -13.32% |
| 2022 | 19.43% | -17.79% |
| 2021 | 23.64% | -8.06% |
| 2020 | 25.71% | -920.11% |
| 2019 | -3.14% | -114.82% |
| 2018 | 21.16% | 18.51% |
| 2017 | 17.85% | 7.38% |
| 2016 | 16.62% | 7.02% |
The current ROE of Ipsen S.A. (IPSEF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.79%
5-year avg
15.69%
10-year avg
15.67%
Ipsen S.A.’s ROE is less than IHH Healthcare Berhad (6.99%), less than Universal Health Services, Inc. (20.66%), less than Eisai Co., Ltd. (4.77%), less than Hangzhou Tigermed Consulting Co., Ltd (3.69%), less than Lee's Pharmaceutical Holdings Limited (4.61%), less than Kaken Pharmaceutical Co., Ltd. (1.46%), less than Adcock Ingram Holdings Limited (15.27%), greater than Indivior PLC (-216.13%), greater than Indivior PLC (-216.13%), less than China Shineway Pharmaceutical Group Limited (11.97%),
| Company | ROE | Market cap |
|---|---|---|
| 6.99% | $15.11B | |
| 20.66% | $10.46B | |
| 4.77% | $17.64B | |
| 3.69% | $6.86B | |
| 4.61% | $112.06M | |
| 1.46% | $984.58M | |
| 15.27% | $624.32M | |
| -216.13% | $3.01B | |
| -216.13% | $2.89B | |
| 11.97% | $758.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ipsen S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ipsen S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ipsen S.A.'s ROE?
How is the ROE calculated for Ipsen S.A. (IPSEF)?
What is the highest ROE for Ipsen S.A. (IPSEF)?
What is the 3-year average ROE for Ipsen S.A. (IPSEF)?
What is the 5-year average ROE for Ipsen S.A. (IPSEF)?
How does the current ROE for Ipsen S.A. (IPSEF) compare to its historical average?